Nirmish R. Shah
Elite in Anemia

Dr. Nirmish R. Shah

Hematology | Pediatrics
Duke Health
Duke Adult Comprehensive Sickle Cell Center - Clinic 2N
40 Duke Medicine Cir, 
Durham, NC 
On Staff At
Accepting New Patients
Offers Telehealth

Elite in Anemia
Duke Health
Duke Adult Comprehensive Sickle Cell Center - Clinic 2N
40 Duke Medicine Cir, 
Durham, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

As director of Duke’s sickle cell transition program, my practice and research focuses on treating children and adults with sickle cell disease. When I work with children, I try to focus on teaching them about their condition and how to transition successfully to living with the disease as an adult. For all patients, I focus on providing the medical, social and psychological support they need to remain healthy. My research aims to increase engagement of sickle cell patients with their own care using mobile technology. Through the use of applications, we’re hoping to help patients, specifically children, better manage their symptoms and medications. Outside of work, I have a strong interest in art. In fact, one of my undergraduate majors was biological illustration. I enjoy drawing plants, animals and people. I’ve recently started getting back into this hobby.

Dr. Shah is rated as an Elite provider by MediFind in the treatment of Anemia. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant.

His clinical research consists of co-authoring 125 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 102 articles and participated in 11 clinical trials in the study of Anemia.

Specialties
Hematology
Pediatrics
Licenses
Internal Medicine in NC
Fellowships
Adult Hematology-Oncology, Pitt County Memorial Hospital (North Carolina), Pediatric Hematology-Oncology, Duke University Medical Center
Hospital Affiliations
Duke University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Duke Adult Comprehensive Sickle Cell Center - Clinic 2N
40 Duke Medicine Cir, Durham, NC 27710
Call: 919-684-6464

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


12 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises
Enrollment Status: Completed
Publish Date: December 02, 2025
Intervention Type: Drug
Study Drug: Inclacumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises
Enrollment Status: Terminated
Publish Date: December 11, 2024
Intervention Type: Drug
Study Drug: Inclacumab
Study Phase: Phase 3
An Open Label, Observational, Prospective Registry of Participants With Sickle Cell Disease (SCD) Treated With Oxbryta® (Voxelotor)
An Open Label, Observational, Prospective Registry of Participants With Sickle Cell Disease (SCD) Treated With Oxbryta® (Voxelotor)
Enrollment Status: Terminated
Publish Date: November 25, 2024
Intervention Type: Drug
A Phase 2, Multicenter, Open-Label Study to Assess PK/PD of SEG101 (Crizanlizumab), With or Without Hydroxyurea/Hydroxycarbamide, in Sickle Cell Patients With Vaso-Occlusive Crisis
A Phase 2, Multicenter, Open-Label Study to Assess PK/PD of SEG101 (Crizanlizumab), With or Without Hydroxyurea/Hydroxycarbamide, in Sickle Cell Patients With Vaso-Occlusive Crisis
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Crizanlizumab
Study Phase: Phase 2
Patient-Empowered Mobile Technology in Hospitalized Patients: Technology Resources to Understand Pain Assessment in Patients With Pain (TRU-PAIN)
Patient-Empowered Mobile Technology in Hospitalized Patients: Technology Resources to Understand Pain Assessment in Patients With Pain (TRU-PAIN)
Enrollment Status: Completed
Publish Date: May 23, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Retrospective Data Collection and Analysis Study of Patients With Sickle Cell Disease (SCD) Who Have Been Treated With Oxbryta® (Voxelotor)
A Retrospective Data Collection and Analysis Study of Patients With Sickle Cell Disease (SCD) Who Have Been Treated With Oxbryta® (Voxelotor)
Enrollment Status: Completed
Publish Date: March 06, 2024
Intervention Type: Drug
Integration of mHEALTH Into the Care of Patients With Sickle Cell Disease to Increase Hydroxyurea Utilization- mESH Study
Integration of mHEALTH Into the Care of Patients With Sickle Cell Disease to Increase Hydroxyurea Utilization- mESH Study
Enrollment Status: Completed
Publish Date: November 29, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
A Phase 4, Multicenter, Open-label Study to Evaluate the Treatment Effect of Voxelotor on Physical Activity in Adolescents and Adults With Sickle Cell Disease
A Phase 4, Multicenter, Open-label Study to Evaluate the Treatment Effect of Voxelotor on Physical Activity in Adolescents and Adults With Sickle Cell Disease
Enrollment Status: Completed
Publish Date: November 21, 2023
Intervention Type: Drug
Study Drug: Voxelotor
Study Phase: Phase 4
Early Low-dose Ketamine Infusion Versus Usual Care for Sickle Cell Pain Crisis: a Randomized, Prospective Study.
Early Low-dose Ketamine Infusion Versus Usual Care for Sickle Cell Pain Crisis: a Randomized, Prospective Study.
Enrollment Status: Withdrawn
Publish Date: January 14, 2022
Intervention Type: Drug, Other
Study Phase: Phase 4
Adjuvant Low Dose Rituximab for Acquired TTP With Severe ADAMTS13 Deficiency
Adjuvant Low Dose Rituximab for Acquired TTP With Severe ADAMTS13 Deficiency
Enrollment Status: Completed
Publish Date: August 17, 2021
Intervention Type: Biological
Study Phase: Phase 2
Use of a Mobile-based Pain Assessment Application for SCD Patients
Use of a Mobile-based Pain Assessment Application for SCD Patients
Enrollment Status: Completed
Publish Date: July 16, 2019
Use of Mobile Technology for Intensive Training in Medication Management
Use of Mobile Technology for Intensive Training in Medication Management
Enrollment Status: Completed
Publish Date: May 25, 2017
Intervention Type: Behavioral
Study Phase: Not Applicable
View 11 Less Clinical Trials

125 Total Publications

Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies.
Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies.
Journal: Blood reviews
Published: December 28, 2024
View All 125 Publications
Similar Doctors
Marilyn J. Telen
Elite in Anemia
Dr. Marilyn J. Telen
Hematology
Elite in Anemia
Dr. Marilyn J. Telen
Hematology

Duke Adult Comprehensive Sickle Cell Center - Clinic 2N

40 Duke Medicine Cir, 
Durham, NC 
 (0.1 miles away)
919-684-6464
Languages Spoken:
English, French, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Marilyn Telen is a Hematologist in Durham, North Carolina. Dr. Telen is rated as an Elite provider by MediFind in the treatment of Anemia. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia. Dr. Telen is currently accepting new patients.

Elite in Anemia
Dr. Jane A. Little
Hematology Oncology | Hematology | Oncology
Elite in Anemia
Dr. Jane A. Little
Hematology Oncology | Hematology | Oncology

University Of North Carolina At Chapel Hill

101 Manning Dr, 
Chapel Hill, NC 
 (9.5 miles away)
984-974-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jane Little is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Little is rated as an Elite provider by MediFind in the treatment of Anemia. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Little is currently accepting new patients.

Distinguished in Anemia
Dr. Nigel S. Key
Hematology Oncology | Hematology
Distinguished in Anemia
Dr. Nigel S. Key
Hematology Oncology | Hematology

University Of North Carolina At Chapel Hill

101 Manning Dr, 
Chapel Hill, NC 
 (9.5 miles away)
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Nigel Key is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Key is rated as an Elite provider by MediFind in the treatment of Anemia. His top areas of expertise are Hemophilia B, Hemophilia A, Blood Clots, Sickle Cell Disease, and Hip Replacement. Dr. Key is currently accepting new patients.

VIEW MORE ANEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shah's expertise for a condition
ConditionClose
  • Elite
  • Anemia
    Dr. Shah is
    Elite
    . Learn about Anemia.
    See more Anemia experts
  • Congenital Hemolytic Anemia
    Dr. Shah is
    Elite
    . Learn about Congenital Hemolytic Anemia.
    See more Congenital Hemolytic Anemia experts
  • Hemoglobinopathy
    Dr. Shah is
    Elite
    . Learn about Hemoglobinopathy.
    See more Hemoglobinopathy experts
  • Hemolytic Anemia
    Dr. Shah is
    Elite
    . Learn about Hemolytic Anemia.
    See more Hemolytic Anemia experts
  • Sickle Cell Disease
    Dr. Shah is
    Elite
    . Learn about Sickle Cell Disease.
    See more Sickle Cell Disease experts
    • Advanced
    • Chronic Pain
      Dr. Shah is
      Advanced
      . Learn about Chronic Pain.
      See more Chronic Pain experts
    • Hemoglobin C Disease
      Dr. Shah is
      Advanced
      . Learn about Hemoglobin C Disease.
      See more Hemoglobin C Disease experts
    • Hemoglobin E Disease
      Dr. Shah is
      Advanced
      . Learn about Hemoglobin E Disease.
      See more Hemoglobin E Disease experts
    • Hemoglobin SC Disease
      Dr. Shah is
      Advanced
      . Learn about Hemoglobin SC Disease.
      See more Hemoglobin SC Disease experts
    • Experienced
    • Adult Immune Thrombocytopenia
      Dr. Shah is
      Experienced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Aplastic Anemia
      Dr. Shah is
      Experienced
      . Learn about Aplastic Anemia.
      See more Aplastic Anemia experts
    • Beta Thalassemia
      Dr. Shah is
      Experienced
      . Learn about Beta Thalassemia.
      See more Beta Thalassemia experts
    • Bone Marrow Transplant
      Dr. Shah is
      Experienced
      . Learn about Bone Marrow Transplant.
      See more Bone Marrow Transplant experts
    • Hemangioma Thrombocytopenia Syndrome
      Dr. Shah is
      Experienced
      . Learn about Hemangioma Thrombocytopenia Syndrome.
      See more Hemangioma Thrombocytopenia Syndrome experts
    • Hemolytic Crisis
      Dr. Shah is
      Experienced
      . Learn about Hemolytic Crisis.
      See more Hemolytic Crisis experts
    View All 12 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.